Coya Therapeutics
Cash Flow

Last updated:

Cash flow statement presents a set of outflows and inflows of cash within a company through operating, investing and financing activities. Over the last year, operating activities of Coya Therapeutics generated cash of -$11,188,811, which is less than the previous year. Cash used in financing activities reached the amount of $38,425,063 last year. Net change in cash is therefore $26,693,066.

Cash Flow

Coya Therapeutics, Inc. (NASDAQ:COYA): Cash Flow
2020 -391.26K 0 9.11M
2021 -3.90M -136.80K -340.58K
2022 -7.23M -525K 9.35M
2023 -11.18M -543.18K 38.42M

COYA Cash Flow Statement (2020 – 2023)

2023 2022 2021 2020
Cash at beginning of period
5.93M4.34M8.72M0
Operating activities
Net income
-7.98M-12.24M-4.89M-733.19K
Adjustments to reconcile net income to cash generated by operating activities:
Depreciation and amortization
27.36K27.36K16.13K0
Stock-based compensation expense
872.24K207.34K233.22K0
Deferred income tax benefit 872.24K207.34K233.22K0
Changes in operating assets and liabilities:
Accounts receivable, net
0000
Inventories
0000
Accounts payable
298.81K845.28K665.16K105.22K
Cash generated by operating activities
-11.18M-7.23M-3.90M-391.26K
Investing activities
Purchases Of Investments
0000
Investments In Property Plant And Equipment
00-136.80K0
Acquisitions Net
0000
Cash generated by investing activities
-543.18K-525K-136.80K0
Financing activities
Common Stock Issued
38.33M1581.31K9.11M
Payments for dividends
0000
Repurchases of common stock
0000
Repayments of term debt
010.46M00
Cash used in financing activities
38.42M9.35M-340.58K9.11M
Net Change In Cash
26.69M1.59M-4.38M8.72M
Cash at end of period
32.62M5.93M4.34M8.72M
Data sourceData source